Harm Westdorp is a clinical PhD
student at the Department of Tumor Immunology.
In 2010 he received his medical
degree at the Radboud University Nijmegen.
In 2013 he started his PhD project
in the group of Professor Jolanda de Vries on the clinical
apllication of dendritic cell vaccination in melanoma, prostate
cancer, and Lynch syndrome healthy carriers and patients. The PhD
project is combined with the residency in Internal Medicine and